Home/Filings/4/0001104659-16-096010
4//SEC Filing

MARINUS PHARMACEUTICALS INC 4

Accession 0001104659-16-096010

CIK 0001267813operating

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 5:17 PM ET

Size

8.3 KB

Accession

0001104659-16-096010

Insider Transaction Report

Form 4
Period: 2015-11-06
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2015-11-06$5.61/sh+3,561$19,977116,085 total
  • Exercise/Conversion

    Common Stock

    2016-02-09$1.04/sh+24,684$25,671140,769 total
  • Exercise/Conversion

    Employee stock option (right to buy)

    2016-02-0924,68431,662 total
    Exercise: $1.04Exp: 2023-04-04Common Stock (24,684 underlying)
Footnotes (1)
  • [F1]17,596 shares vested on 04/04/2013; remaining shares vest in 43 equal monthly installments

Documents

1 file

Issuer

MARINUS PHARMACEUTICALS INC

CIK 0001267813

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001267813

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:17 PM ET
Size
8.3 KB